Publications Database

Cortesi F. et al. (2012)

Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial

Journal of Sleep Research

21(6), pp. 700-709.

Read Abstract (New Window)

Dadds M. R. et al. (2014)

Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial.

Journal of Autism and Developmental Disorders

44(3), pp. 521-531.

Read Abstract (New Window)

David , Geier D. A. , Geier M. R. (2006)

The biochemical basis and treatment of autism: interactions between mercury, transsulfuration, and androgens.

Autoimmunity Reviews

Read Full (New Window)

DeMayo M. M. et al.

A review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: Therapeutic potential for autism and Prader-Willi syndrome, and recommendations for future research.

Pediatric Drugs

Read Abstract (New Window)

Didden R. (2001)

A review of the nature and treatment of sleep disorders in individuals with developmental disabilities.

Research in Developmental Disabilities

22(4), pp. 255-272

Read Abstract (New Window)

Domes G. et al. (2013)

Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.

Biological Psychiatry

74(3), pp. 164-171.

Read Abstract (New Window)

Doyen C. et al. (2011)

Melatonin in children with autistic spectrum disorders: recent and practical data.

European Child and Adolescent Psychiatry

20(5), pp. 231-239

Read Abstract (New Window)

Dunn-Geier J. et al. (2000)

Effect of secretin on children with autism: a randomized controlled trial.

Developmental Medicine and Child Neurology

42(12),

Read Abstract (New Window)

Esch B. E. , Carr J. E. (2004)

Secretin as a treatment for autism: a review of the evidence.

Journal of Autism and Developmental Disorders

October, 34(5), pp. 543-556.

Read Abstract (New Window)

Therapeutic Research Faculty (2010)

Melatonin.

Bethesda, MD: Therapeutic Research Faculty

Read Full (New Window)

Farmer C. A. , Thurm A. , Grant P. J. (2013)

Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research.

Drugs

73(4), pp. 303-314.

Read Abstract (New Window)

Fukai M. et al. (2017)

Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study.

Psychiatry Research: Neuroimaging

267 pp. 45-50.

Read Abstract (New Window)

Galli-Carminati G. , Deriaz N. , Bertschy G. (2009)

Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study.

Swiss Medical Weekly

139(19), pp. 293-296

Read Abstract (New Window) Read Full (New Window)

Garstang J. , Wallis M. (2006)

Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems.

Child: Care, Health and Development

32(5), pp. 585-589

Read Abstract (New Window)

Gbadebo O. S. (2011)

Reduced maladaptive behavior and improved social function in a child with PDD-NOS treated with progesterone.

Clinical Medicine and Research

9(2), pp. 100 -102

Read Abstract (New Window)

Ghanizadeh A. (2010)

Targeting neurotensin as a potential novel approach for the treatment of autism.

Journal of Neuroinflammation

(7), pp. 58

Read Abstract (New Window) Read Full (New Window)

Gordon I. et al. (2013)

Oxytocin enhances brain function in children with autism.

Proceedings of the National Academy of Science U S A

110(52), pp. 20953-20958.

Read Abstract (New Window) Read Full (New Window)

Gringras P. et al. (2017)

Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 56(11), pp. 948-957.

Read Abstract (New Window) Read Full (New Window)

Gringras P. et al. (2012)

Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.

British Medical Journal

345 e6664

Read Full (New Window)

Gringras P. (2000)

Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls.

Autism

4(3), pp. 229-247

Read Abstract (New Window)